Data collected revealed that circulating NKT from COVID-19 patients produced significantly less IFN-γ but more IL-17 compared with cells from healthy donors even if these cytokines were more represented in ETAs than plasma [39], and decreased the production of IL-12A and IL-10 compared to control [44] (See Table S1). This evidence concerns the gene IL10 and COVID-19.